The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.
نویسندگان
چکیده
Congenital and acquired deficiencies of complement regulatory proteins are associated with pathologic complement activation in several renal diseases. To elucidate the mechanisms by which renal tubular epithelial cells (TECs) control the complement system, we examined the expression of complement regulatory proteins by the cells. We found that Crry is the only membrane-bound complement regulator expressed by murine TECs, and its expression is concentrated on the basolateral surface. Consistent with the polarized localization of Crry, less complement activation was observed when the basolateral surface of TECs was exposed to serum than when the apical surface was exposed. Furthermore, greater complement activation occurred when the basolateral surface of TECs from Crry(-/-)fB(-/-) mice was exposed to normal serum compared with TECs from wild-type mice. Complement activation on the apical and basolateral surfaces was also greater when factor H, an alternative pathway regulatory protein found in serum, was blocked from interacting with the cells. Finally, we injected Crry(-/-)fB(-/-) and Crry(+/+)fB(-/-) mice with purified factor B (an essential protein of the alternative pathway). Spontaneous complement activation was seen on the tubules of Crry(-/-)fB(-/-) mice after injection with factor B, and the mice developed acute tubular injury. These studies indicate that factor H and Crry regulate complement activation on the basolateral surface of TECs and that factor H regulates complement activation on the apical surface. However, congenital deficiency of Crry or reduced expression of the protein on the basolateral surface of injured cells permits spontaneous complement activation and tubular injury.
منابع مشابه
Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia reperfusion injury
The murine cell surface protein Crry (complement receptor 1-related protein/gene y) is a key complement regulator with similar activities to human membrane cofactor protein (MCP) and decay-accelerating factor. MCP has a critical role in preventing complement-mediated tissue injury and its mutation has been implicated in several human kidney diseases. The study of Crry in mice has relevance to u...
متن کاملAltered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.
Ischemia/reperfusion (I/R) of several organs results in complement activation, but the kidney is unique in that activation after I/R occurs only via the alternative pathway. We hypothesized that selective activation of this pathway after renal I/R could occur either because of a loss of complement inhibition or from increased local synthesis of complement factors. We examined the relationship b...
متن کاملTranslational Nephrology A Crry for polar shedding
Renal ischaemia plays a crucial role in the pathogenesis of acute renal failure. This ischaemia is also the primary factor in radio-contrast nephropathy, kidney transplantation and the progression of various kinds of chronic kidney diseases. Ischaemic renal failure is associated with the loss of tubular epithelial cell polarity [1,2]. This change in cell polarity has multiple functional sequela...
متن کاملUnrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
Deficiency of the C3 convertase regulator Crry is embryonic lethal in mice unless C3 also is absent. For evaluation of the effect of local kidney Crry deficiency in the setting of an intact complement system, Crry(-/-)C3(-/-) mouse kidneys were transplanted into syngeneic C57BL/6 wild-type mice. These Crry-deficient kidneys developed marked inflammatory cell infiltration, tubular damage, and in...
متن کاملTUBULAR ISCHEMIA AND TOXICITY TO035 ENDOTHELIAL PROGENITOR CELL-DERIVED EXTRACELLULAR VESICLES INHIBIT KIDNEY ISCHEMIA-REPERFUSION INJURY THROUGH THE TRANSFEROF mRNAs CODING FOR COMPLEMENT INHIBITORS TO INJURED TUBULAR EPITHELIAL AND ENDOTHELIAL CELLS
Introduction and Aims: Endothelial progenitor cells (EPCs) are bone marrow-derived precursors known to reverse acute kidney injury (AKI) by paracrine mechanisms including the release of extracellular vesicles (EVs), small particles playing a role in intercellular communication through the transfer of proteins and RNAs. Activation of the complement cascade in tubular epithelial and endothelial c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of immunology
دوره 185 5 شماره
صفحات -
تاریخ انتشار 2010